Quick Links
  • ASMS


  • CMSS


  • TSMS




Home>About CASMS>Annual Meeting and Programs

The Member Connections Committee

  • Co-Chair:Wilson Shou

    Wilson Shou (寿臻宇) is a Director, Discovery Chemistry Platforms at Bristol-Myers Squibb’s R&D site in Princeton, NJ. Wilson received his B.S. in Analytical Chemistry from Fudan University in 1995, and his Ph.D. in Analytical Chemistry from Georgia Institute of Technology in

    1999 under the direction of Professor Richard F. Browner. After graduation, he joined Covance Laboratories in Madison, WI and conducted research in bioanalytical mass spectrometry in support of various DMPK studies ranging from early PK screening to regulated preclinical and clinical projects. In 2005, he moved to Bristol-Myers Squibb, where he has been leading a bioanalytical group supporting the company-wide high-throughput in vitro ADME profiling effort. Wilson’s research interests involve the application of mass spectrometry, separation sciences and software/automation tools for the high-throughput bioanalysis of small molecules and peptides in support of lead discovery and optimization. He has authored/co-authored 48 journal articles, 4 book chapters, and more than 70 podium or poster presentations. Wilson was the guest editor for a special issue of Bioanalysis focusing on Discovery Bioanalysis in 2012, and also co-edited a book entitled “Eliminating bottlenecks for efficient bioanalysis: practices and applications in drug discovery and development” in 2014. He is currently on the editorial board of Biomedical Chromatography. Wilson has served on the organizing committees for a number of international conferences, and also organized and chaired multiple oral sessions at ASMS, SLAS and PITTCON. He has been a committee member of the annual HT-ADME conference since its inception in 2011, and served as the conference chair in 2013. Wilson is also currently serving a two-year term on the ASMS Nominating Committee.

    More >>
  • Co-Chair:Lan Huang

    Lan Huang is Professor of Physiology & Biophysics in School of Medicine, University of California, Irvine. Her research focuses on developing novel, integrated mass spectrometry-based proteomic strategies to characterize dynamic proteomes of macromolecular protein complexes

    and understand their functions, particularly those in the ubiquitin-proteasome system. Through the years, the Huang lab has developed various novel methodologies to capture, purify and quantify protein-protein interactions of protein complexes in living cells. In addition, her lab has developed a new class of cross-linking reagents, i.e. sulfoxide-containing MS-cleavable cross-linkers (e.g. DSSO), and thus established a robust cross-linking mass spectrometry (XL-MS) platform enabling fast and accurate identification of cross-linked peptides. These XL-MS strategies have been successfully employed to determine protein interaction interfaces and derive structural topologies of protein complexes in vitro and in vivo. The strategies developed by her group have proven highly effective as general proteomic tools for studying protein complexes. She has co-authored more than 120 peer-reviewed research articles. She has served on multiple committees for professional societies including ASMS, ASBMB, US HUPO and CASMS organizations. She has been an Ad hoc reviewer for many journals and funding agencies, and currently serves on NIH study section. She has served as co-organizers for numerous international conferences including US HUPO annual meeting (2015 and 2020), ASMS Sanibel meeting (2019), and Gordon conferences (2015 & 2017). She has been an Editorial Board member of Molecular & Cellular Proteomics since 2007 and an Associate Editor for FASEB BioAdvances since 2019.

    More >>
  • Member:Hui Zhang(Past-Co-Chair )

    Dr. Hui Zhang is a professor of Pathology, Oncology, Chemical and Biomoledular Engineering of Johns Hopkins University. She is the director of the Mass Spectrometry Core Facility in the Center for Biomarker Discovery and Translation. Dr. Zhang studies protein modifications on

    the proteome scale and the effects of protein modifications on protein functions and disease development. For the past few years, her laboratory has developed several novel glycoproteomic and glycomic technologies to study cell surface glycoproteins and secreted glycoproteins. Currently, researchers in her group focus on understanding the functions of protein modifications in biology and human diseases.

    More >>
Level of Sponsorship

Diamond Sponsors

Platinum Sponsors

Gold Sponsors

Silver Sponsors

Bronze Sponsors

Media Sponsors